Compare
Insulet Corp vs Globus Medical Inc vs West Pharmaceutical Services Inc vs ICU Medical Inc
| Latest fiscal year | Insulet Corp PODD | Globus Medical Inc GMED | West Pharmaceutical Services Inc WST | ICU Medical Inc ICUI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.71B | $2.94B | $3.07B | $2.23B |
| Revenue growth (YoY) | +30.7% | +16.7% | +6.3% | -6.3% |
| Gross margin | 71.6% | 67.4% (computed) | 35.9% | 36.8% |
| Operating margin | 17.5% | 16.3% | 19.0% | 1.9% |
| Net margin | 9.1% | 18.3% | 16.1% | 0.0% |
| Net income | $247.10M | $537.87M | $493.70M | $732.0K |
| EPS (Diluted) | $3.48 | $3.92 | $6.79 | $0.03 |
| Operating cash flow | $569.30M | $753.45M | $754.80M | $179.85M |
| Free cash flow | $377.70M | $588.77M | $468.90M | $91.80M |
| Cash & equivalents | n/a | $526.16M | $791.30M | n/a |
| Total assets | $3.19B | $5.30B | $4.27B | $4.05B |
| Total liabilities | $1.68B | $729.51M | $1.09B | n/a |
| Shareholders' equity | $1.52B | $4.57B | $3.18B | $2.12B |
| Return on year-end equity | 16.3% | 11.8% | 15.5% | 0.0% |
| Shares outstanding | 70.39M | n/a | 72.00M | 24.69M |
Revenue, most recent five fiscal years
| Fiscal year | Insulet Corp | Globus Medical Inc | West Pharmaceutical Services Inc | ICU Medical Inc |
|---|---|---|---|---|
| Latest | $2.71B Ended 2025-12-31 | $2.94B Ended 2025-12-31 | $3.07B Ended 2025-12-31 | $2.23B Ended 2025-12-31 |
| 1 year earlier | $2.07B Ended 2024-12-31 | $2.52B Ended 2024-12-31 | $2.89B Ended 2024-12-31 | $2.38B Ended 2024-12-31 |
| 2 years earlier | $1.70B Ended 2023-12-31 | $1.57B Ended 2023-12-31 | $2.95B Ended 2023-12-31 | $2.26B Ended 2023-12-31 |
| 3 years earlier | $1.31B Ended 2022-12-31 | $1.02B Ended 2022-12-31 | $2.89B Ended 2022-12-31 | $2.28B Ended 2022-12-31 |
| 4 years earlier | $1.10B Ended 2021-12-31 | $958.10M Ended 2021-12-31 | $2.83B Ended 2021-12-31 | $1.32B Ended 2021-12-31 |